Femasys (FEMY) Cash & Equivalents Growth (1y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | -23.33% |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | 21.89% |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 78.03% |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | 29.00% |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | - |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 23.79% |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | 21.40% |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | -11.94% |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | 76.84% |
| 10 | Femasys | 22.30 Mn | 16.91 Mn | - | 40.99% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 40.99% |
| Dec 31, 2025 | 168.45% |
| Sep 30, 2025 | -39.97% |
| Jun 30, 2025 | -76.21% |
| Mar 31, 2025 | -78.58% |
| Dec 31, 2024 | -84.11% |
| Sep 30, 2024 | -12.44% |
| Jun 30, 2024 | 26.35% |
| Mar 31, 2024 | 75.53% |
| Dec 31, 2023 | 67.54% |
| Sep 30, 2023 | -45.69% |
| Jun 30, 2023 | -44.00% |
| Mar 31, 2023 | -53.32% |
| Dec 31, 2022 | -47.70% |
| Sep 30, 2022 | -41.33% |
| Jun 30, 2022 | -35.98% |
| Dec 31, 2021 | 645.98% |